Freedom Capital Markets Maintains Buy on Nutex Health, Raises Price Target to $306
Freedom Capital Markets analyst Gene Mannheimer maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $280 to $306.
Share
Why It Matters
An expert investor watcher thinks Nutex Health is worth watching. They raised how much they think the stock could grow.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.